Compare Plug Power Inc (PLUG) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plug Power Inc vs 10X Genomics Inc — how do they compare? Plug Power Inc trades at $2.24 (market cap $2.98B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals.
| PLUG | TXG | |
|---|---|---|
Market Cap | $2.98B | $5.48B |
Sector | Industrials | Health |
52-Week High | $4.14 | $47.20 |
52-Week Low | $1.40 | $11.34 |
Enterprise Value | $3.77B | $5.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $2.27, up 5.58% on the day, but remains in a bearish technical trend with oversold RSI readings. The company shows persistent unprofitability with a -227.13% net margin and negative cash flows, though recent earnings have beaten estimates in two of the last three quarters. Positive developments include a 50-megawatt electrolyzer order in Australia and strategic asset sales aimed at boosting liquidity by over $275 million, providing some operational momentum amid financial challenges.
The outlook remains high-risk due to deep losses and cash burn, but analyst consensus is cautiously optimistic with a $2.92 price target (28% upside). Investment opportunity hinges on successful turnaround execution and hydrogen demand growth, while key risks include continued dilution, competitive pressure, and reliance on financing to fund operations. The stock's depressed valuation reflects significant skepticism, leaving room for volatility on news flow.
TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.
The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
